Drug Profile
Arterolane/piperaquine - Sun Pharmaceutical Industries
Alternative Names: Arterolane maleate/piperaquine phosphate; SynriamLatest Information Update: 29 Mar 2019
Price :
$50
*
At a glance
- Originator Medicines for Malaria Venture; Ranbaxy Laboratories
- Developer Sun Pharmaceutical Industries
- Class 1 ring heterocyclic compounds; Antimalarials; Peroxides; Piperazines; Quinolines; Small molecules; Spiro compounds
- Mechanism of Action Adenosine triphosphatase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Falciparum malaria; Vivax malaria
Most Recent Events
- 29 Mar 2019 Chemical structure information added
- 06 Aug 2015 Launched for Falciparum malaria in Nigeria (PO) before August 2015
- 25 Mar 2015 Ranbaxy Laboratories has been acquired by Sun Pharmaceutical Industries